vision
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
vision
Jun 11, 2024, 22:40 |
Blog
Rashid Sayyid: RW study of LuPSMA in VISION-eligible mCRPC patients
Rashid Sayyid, Urologic Oncology Clinical Fellow at University of Toronto, shared a post on X: "RW study of…
Apr 15, 2024, 14:41 |
Drugs
Piotr Wysocki: The [177Lu]Lu-PSMA-617 plus enzalutamide combination is active and safe in mCRPC patients, but is it really an option for first-line treatment?
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Aug 7, 2023, 18:11 |
Blog
What mattered most to Susan Love was the research and her vision for a world without breast cancer - Christopher Clinton Conway
The Vision What mattered most to Susan Love was the research and her vision for…
Jul 1, 2023, 14:37 |
Blog
Dr. Louis DeGennaro helped advance 70% of the 110 blood cancer treatments approved by the FDA in the last six years - The Leukemia & Lymphoma Society
As LLS President & CEO Dr. Louis DeGennaro officially retires on 7/1, we reflect on the incredible…
All:
4
Posts:
1 - 100
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube